Nour I, Mohanty SK (2024) Avian reovirus: from molecular biology to pathogenesis and control. Viruses 16(12):1966
Article CAS PubMed Central PubMed Google Scholar
DeAntoneo C, Danthi P, Balachandran S (2022) Reovirus activated cell death pathways. Cells 11(11):1757
Article CAS PubMed Central PubMed Google Scholar
Wu YY, Chen MS, Liao TL, Munir M, Liu HJ (2025) Oncolytic viruses in cancer therapy: exploring the mechanisms and clinical potential of mammalian and avian reoviruses. Tungs Med J 19(1):19–26
Dulińska-Litewka J, Łazarczyk A, Hałubiec P, Szafrański O, Karnas K, Karewicz A (2019) Superparamagnetic iron oxide nanoparticles—current and prospective medical applications. Materials 12(4):617
Article PubMed Central PubMed Google Scholar
Banerjee R (2025) Synthetic biology-based approaches to investigate host–pathogen interactions. SynBio 3(1):4
Nouda R, Minami S, Kanai Y, Kawagishi T, Nurdin JA, Yamasaki M et al (2021) Development of an entirely plasmid-based reverse genetics system for 12-segmented double-stranded RNA viruses. Proc Natl Acad Sci USA 118(42):e2105334118
Article CAS PubMed Central PubMed Google Scholar
Wang W, Shang S, Wang Y, Xu B (2024) Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging. Front Bioeng Biotechnol 12:1484577
Article PubMed Central PubMed Google Scholar
Lechermann LM, Lau D, Attili B, Aloj L, Gallagher FA (2021) In vivo cell tracking using PET: opportunities and challenges for clinical translation in oncology. Cancers (Basel) 13(16):4042
Article CAS PubMed Central PubMed Google Scholar
Liu S, Su Y, Lin MZ, Ronald JA (2021) Brightening up biology: advances in luciferase systems for in vivo imaging. ACS Chem Biol 16(12):2707–2718
Article CAS PubMed Central PubMed Google Scholar
Köse G, Darguzyte M, Kiessling F (2020) Molecular ultrasound imaging. Nanomaterials 10(10):1935
Article PubMed Central PubMed Google Scholar
Oh SH, Altug H, Jin X, Low T, Koester SJ, Ivanov AP et al (2021) Nanophotonic biosensors harnessing van der Waals materials. Nat Commun 12(1):3824
Article CAS PubMed Central PubMed Google Scholar
Mallozzi A, Fusco V, Ragazzini F, Di Bernardo D (2024) A biomolecular circuit for automatic gene regulation in mammalian cells with CRISPR technology. ACS Synth Biol 13(12):3917–3925
Article CAS PubMed Central PubMed Google Scholar
Laxmi B, Devi PUM, Thanjavur N, Buddolla V (2024) The applications of artificial intelligence (AI)-driven tools in virus-like particles (VLPs) research. Curr Microbiol 81(8):234
Article CAS PubMed Google Scholar
Zamora-Vargas PF (2018) Functions of the nonstructural protein σNS in reovirus replication. PhD thesis, Vanderbilt University, Nashville, TN
Shepherd FK, Freeman MJ, Culhane MR, Marthaler DG (2019) Reoviruses (rotaviruses and reoviruses). Diseases of swine. pp 715–27
Liu Y, Wang M, Cheng A, Yang Q, Wu Y, Jia R et al (2020) The role of host eIF2α in viral infection. Virol J 17(1):112
Article CAS PubMed Central PubMed Google Scholar
Kemp V, Hoeben RC, den Van Wollenberg DJM (2015) Exploring reovirus plasticity for improving its use as oncolytic virus. Viruses 8(1):4
Article PubMed Central PubMed Google Scholar
Phillips MB, Stuart JD, Rodríguez Stewart RM, Berry JTL, Mainou BA, Boehme KW (2018) Current understanding of reovirus oncolysis mechanisms. Oncolytic Virother. https://doi.org/10.2147/ov.s143808
Article PubMed Central PubMed Google Scholar
Russell L, Peng KW (2018) The emerging role of oncolytic virus therapy against cancer. Chin Clin Oncol 7(2):16
Article PubMed Central PubMed Google Scholar
Wicherska-Pawłowska K, Wróbel T, Rybka J (2021) Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) in innate immunity. TLRs, NLRs, and RLRs ligands as immunotherapeutic agents for hematopoietic diseases. Int J Mol Sci 22(24):13397
Article PubMed Central PubMed Google Scholar
Groeneveldt C, Kinderman P, van Stigt Thans JJC, Labrie C, Griffioen L, Sluijter M et al (2022) Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy. J Immunother Cancer 10(7):e004464
Article PubMed Central PubMed Google Scholar
Aghamajidi A, Farhangnia P, Pashangzadeh S, Damavandi AR, Jafari R (2022) Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy. Cancer Cell Int 22(1):327
Article CAS PubMed Central PubMed Google Scholar
White CL, Twigger KR, Vidal L, De Bono JS, Coffey M, Heinemann L et al (2008) Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther 15(12):911–20
Article CAS PubMed Google Scholar
Cai R, Meng G, Li Y, Wang W, Diao Y, Zhao S et al (2019) The oncolytic efficacy and safety of avian reovirus and its dynamic distribution in infected mice. Exp Biol Med 244(12):983–91
Kemp V, Lamfers MLM, Van Der Pluijm G, van den Hoogen BG, Hoeben RC (2020) Developing oncolytic viruses for clinical use: a consortium approach. Cytokine Growth Factor Rev 56:133–40
Article CAS PubMed Google Scholar
Chu T, Zheng X, Manshian BB, Soenen SJ (2025) Optical imaging in biomedical research: guidelines and practical insights. Health Nanotechnology 1(1):4
Lakshmanan K, Liu BM (2025) Impact of point-of-care testing on diagnosis, treatment, and surveillance of vaccine-preventable viral infections. Diagnostics 15(2):123
Article CAS PubMed Central PubMed Google Scholar
Pelin A, Wang J, Bell J, Le Boeuf F (2018) The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses. Oncolytic Virother. https://doi.org/10.2147/ov.s137159
Article PubMed Central PubMed Google Scholar
Ravera S, Reyna-Neyra A, Ferrandino G, Amzel LM, Carrasco N (2017) The sodium/iodide symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol 79(1):261–289
Article CAS PubMed Central PubMed Google Scholar
Muñoz-Álvarez KA, Altomonte J, Laitinen I, Ziegler S, Steiger K, Esposito I et al (2015) PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model. Mol Ther 23(4):728–36
Article PubMed Central PubMed Google Scholar
Eisenman D, Swindle S (2022) Fda guidance on shedding and environmental impact in clinical trials involving gene therapy products. Appl Biosaf 27(3):191–197
Article PubMed Central PubMed Google Scholar
Eskola S, Laenen K, Anquez C (2019) Submission of comments on ‘Guideline on the environmental risk assessment of medicinal products for human use’ (EMEA/CHMP/SWP/4447/00 Rev. 1). European Medicines Agency, London, UK
Comments (0)